Loading clinical trials...
Loading clinical trials...
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
September 29, 1999
Primary Completion Date
September 29, 2030
Completion Date
September 29, 2032
Last Updated
July 22, 2025
2,750
ESTIMATED participants
Lead Sponsor
Dana-Farber Cancer Institute
Collaborators
NCT05006716
NCT07277231
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06859424